Lyra Therapeutics, Inc. - Common Stock (LYRA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
LYRA on Nasdaq
Shares outstanding
1,769,273
Price per share
$1.74
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
242,614
Total reported value
$747,316
% of total 13F portfolios
0%
Share change
-205,974
Value change
-$1,598,144
Number of holders
22
Price from insider filings
$1.74
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lyra Therapeutics, Inc. - Common Stock (LYRA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 9.9% $628,817 175,158 SABBY MANAGEMENT, LLC 31 Dec 2025

As of 31 Dec 2025, 22 institutional investors reported holding 242,614 shares of Lyra Therapeutics, Inc. - Common Stock (LYRA). This represents 14% of the company’s total 1,769,273 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Lyra Therapeutics, Inc. - Common Stock (LYRA) together control 14% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SABBY MANAGEMENT, LLC 9.9% 175,158 +37% 4.5% $539,487
Ikarian Capital, LLC 1.2% 21,161 0% 0.01% $65,176
DRW Securities, LLC 0.95% 16,812 0% $51,780
GEODE CAPITAL MANAGEMENT, LLC 0.69% 12,249 +11% 0% $37,733
Artia Global Partners LP 0.49% 8,756 0% $26,968
BlackRock, Inc. 0.14% 2,394 +42% 0% $7,373
Tower Research Capital LLC (TRC) 0.12% 2,191 +310% 0% $6,748
ROYAL BANK OF CANADA 0.11% 1,928 +46% 0% $6,000
UBS Group AG 0.04% 675 -83% 0% $2,079
EverSource Wealth Advisors, LLC 0.02% 338 -2% 0% $1,041
MORGAN STANLEY 0.02% 334 -74% 0% $1,029
JONES FINANCIAL COMPANIES LLLP 0.01% 210 0% 0% $647
BANK OF AMERICA CORP /DE/ 0.01% 201 +1017% 0% $619
SBI Securities Co., Ltd. 0% 80 0% 0% $246
JPMORGAN CHASE & CO 0% 27 0% 0% $83
COMERICA BANK 0% 23 0% 0% $71
OSAIC HOLDINGS, INC. 0% 22 0% 0% $67
Wilmington Savings Fund Society, FSB 0% 20 0% 0% $62
BNP PARIBAS FINANCIAL MARKETS 0% 16 0% 0% $49
Global Retirement Partners, LLC 0% 15 0% $46
CITIGROUP INC 0% 3 -100% 0% $9
IFP Advisors, Inc 0% 1 -50% 0% $3
CITADEL ADVISORS LLC 0% 0 -100% $0
Signature Resources Capital Management, LLC 0% 0 -100% $0
VANGUARD GROUP INC 0% 0 -100% $0

Institutional Holders of Lyra Therapeutics, Inc. - Common Stock (LYRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 242,614 $747,316 -$1,598,144 $3.08 22
2025 Q3 448,588 $2,933,978 -$324,008 $6.53 25
2025 Q2 493,700 $4,423,417 +$4,423,193 $8.96 29